Vor appointed David Zaccardelli as an independent director, effective July 7, 2026, following the immediate resignation of Andrew Levin.
| IndividualAndrew Levin, M.D., Ph.D.David Zaccardelli, Pharm.D. | RoleDirectorIndependent Class II Director | Type of ChangeResignedAppointed | Effective DateJuly 6, 2026July 7, 2026 | ReasonNot a result of any disagreement with the CompanyTo fill vacancy created by Dr. Levin’s resignation | Replacement InfoReplaced by David ZaccardelliFilled vacancy from Andrew Levin's resignation | Background DetailsNot disclosedFounder & Managing Member of Bull City Select Investments since 2016; former CEO/director of Verona Pharma (2020–2025), Dova Pharmaceuticals (2018–2019), Interim CEO of Cempra (2016–2017); Pharm.D., fellowship in clinical research and drug development | Board/Committee Role ChangesNot disclosedNot appointed to any committee as of the date of the filing |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.